There have been several attempts to use gene microarrays from peripheral blood mononuclear cells to identify new biological pathways or targets for therapy in Posttraumatic Stress Disorder (PTSD). The few studies conducted to date have yielded an unclear pattern of findings, perhaps reflecting the use of heterogeneous samples of circulating immune cells for analysis. We used gene microarrays on a homogeneous sample of circulating monocytes to test the hypothesis that chronic PTSD would be associated with elevated inflammatory activity and to identify new pathways dysregulated in the disorder. Fortynine men (24 PTSD+ and 25 age-matched trauma-exposed PTSDÀ controls) and 18 women (10 PTSD+ and 8 age-matched PTSDÀ controls) were recruited. Gene expression microarray analysis was performed on CD14+ monocytes, immune cells that initiate and respond to inflammatory signaling. Male subjects with PTSD had an overall pattern of under-expression of genes on monocytes (47 under-expressed versus 4 over-expressed genes). A rigorous correction for multiple comparisons and verification with qPCR showed that of only 3 genes that were differentially expressed, all were under-expressed. There was no transcriptional evidence of chronic inflammation in male PTSD+ subjects. In contrast, preliminary data from our pilot female PTSD+ subjects showed a relatively balanced pattern of increased and decreased expression of genes and an increase in activity of pathways related to immune activation. The results indicate differential patterns of monocyte gene expression in PTSD, and the preliminary data from our female pilot subjects are suggestive of gender dimorphism in biologic pathways activated in PTSD. Changes in immune cell gene expression may contribute to medical morbidity in PTSD.
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Introduction
Posttraumatic Stress Disorder (PTSD) is highly prevalent in both military and civilian populations, is chronic and often accompanied by substance abuse, depression, difficulties with interpersonal relationships, poorer occupational functioning and increased physical health problems (Kulka et al., 1990) . A number of studies have demonstrated that PTSD is associated with alterations in immune function (Hoge et al., 2009) . Specifically, PTSD is associated with enhanced cellular immune responses (Altemus et al., 2003; Laudenslager et al., 1998; Watson et al., 1993) , activated T lymphocytes (Wilson et al., 1999) and impaired humoral immunity, as indexed by higher antibody responses to cytomegalovirus levels (Uddin et al., 2010) . PTSD has also been shown to be associated with increased levels of some inflammatory cytokines (Maes et al., 1999a; Spivak et al., 1997; Sutherland et al., 2003) . Finally, PTSD is associated with increased levels of C-reactive protein (Miller et al., 2001) , an index of systemic inflammatory activity, though this has not been found in all studies (Sondergaard et al., 2004) . These findings of altered immune functioning in PTSD have important implications for understanding the high rates of cardiovascular (Cohen et al., 2009; Kubzansky et al., 2007) , musculoskeletal, and neurocognitive disorders associated with PTSD (reviewed in Schnurr et al. (2000) ). Chronic inflammation is well known to be associated with a broad spectrum of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease, amyotrophic lateral sclerosis (ALS), and possibly neuropsychiatric disorders.
Gene expression microarray analysis has facilitated the discovery of genes/pathways/proteins associated with biological and pathological processes. Only in the past few years has this powerful tool been used to elucidate mechanisms of action for psychiatric disorders. Microarray studies in peripheral immune cells in PTSD have the potential to test hypotheses about immune function as well as to explore biological pathways that are expressed in both 0889-1591/$ -see front matter Ó 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2010.12.001
